...
首页> 外文期刊>The American Journal of Cardiology >Evaluating Japanese patients with the Marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene.
【24h】

Evaluating Japanese patients with the Marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene.

机译:使用基于高通量微阵列的原纤维蛋白-1基因突变分析评估日本马凡氏综合征患者。

获取原文
获取原文并翻译 | 示例
           

摘要

Marfan syndrome (MS) is an inherited connective tissue disorder, and detailed evaluations of multiple organ systems are required for its diagnosis. Genetic testing of the disease-causing fibrillin-1 gene (FBN1) is also important in this diagnostic scheme. The aim of this study was to define the clinical characteristics of Japanese patients with MS and enable the efficient and accurate diagnosis of MS with mutational analysis using a high-throughput microarray-based resequencing system. Fifty-three Japanese probands were recruited, and their clinical characteristics were evaluated using the Ghent criteria. For mutational analysis, an oligonucleotide microarray was designed to interrogate FBN1, and the entire exon and exon-intron boundaries of FBN1 were sequenced. Clinical evaluation revealed more pulmonary phenotypes and fewer skeletal phenotypes in Japanese patients with MS compared to Caucasians. The microarray-based resequencing system detected 35 kinds of mutations, including 23 new mutations. The mutation detection rate for patients who fulfilled the Ghent criteria reached 71%. Of note, splicing mutations accounted for 19% of all mutations, which is more than previously reported. In conclusion, this comprehensive approach successfully detected clinical phenotypes of Japanese patients with MS and demonstrated the usefulness and feasibility of this microarray-based high-throughput resequencing system for mutational analysis of MS.
机译:马凡氏综合征(MS)是一种遗传性结缔组织疾病,对其诊断需要对多个器官系统进行详细评估。在该诊断方案中,对引起疾病的原纤维蛋白1基因(FBN1)的基因检测也很重要。这项研究的目的是定义日本MS患者的临床特征,并使用基于高通量微阵列的重测序系统进行突变分析,从而能够有效,准确地诊断MS。招募了53名日本先证者,并根据根特标准对他们的临床特征进行了评估。为了进行突变分析,设计了一种寡核苷酸微阵列来询问FBN1,并对FBN1的整个外显子和外显子-内含子边界进行了测序。临床评估显示,与高加索人相比,日本MS患者的肺表型更多,骨骼表型更少。基于微阵列的重测序系统检测到35种突变,包括23种新突变。符合根特标准的患者的突变检测率达到71%。值得注意的是,剪接突变占所有突变的19%,比以前报道的还要多。总之,这种综合方法成功地检测了日本MS患者的临床表型,并证明了这种基于微阵列的高通量测序系统对MS突变分析的实用性和可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号